Evidence map›Paper›PMID 34684085›Full record

ArticleMedicina (Kaunas, Lithuania)2021

A Seroprevalence Study of Anti-SARS-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease during the Second Wave of the COVID-19 Pandemic in Italy.

Mirko Di Ruscio, Gianluigi Lunardi, Dora Buonfrate, Federico Gobbi, Giulia Bertoli, Donatella Piccoli, Antonio Conti, Andrea Geccherle, Angela Variola

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Observational
  2. High seroprevalence against SARS-CoV-2 in non-vaccinated patients with inflammatory bowel disease from Northern India.Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Mirko Di RuscioIBD Unit, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.ORCID 0000-0002-8077-0405
Gianluigi LunardiMedical Analysis Laboratory, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Dora BuonfrateDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.ORCID 0000-0003-0108-6822
Federico GobbiDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Giulia BertoliDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.ORCID 0000-0003-4175-1620
Donatella PiccoliMedical Analysis Laboratory, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Antonio ContiMedical Analysis Laboratory, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Andrea GeccherleIBD Unit, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Angela VariolaIBD Unit, IRCCS Sacro Cuore Don Calabria Hospital, 37024 Negrar di Valpolicella (VR), Italy.
Ospedale Sacro Cuore Don Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19Inflammatory Bowel DiseasesAntibodies, ViralHumansItalyPandemicsSARS-CoV-2Seroepidemiologic StudiesAntibodies, Viralanti-SARS-CoV-2 antibodiesCOVID-19inflammatory bowel diseaseseroprevalence

Identifiers

PMID34684085
PMCPMC8539305
OpenAlexW3202874814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.